

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805
S473
Table 2
Anova de un factor.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.1375EV391
ADHD “Symptomatic contamination”
in dual pathology (II): Specific analysis
of the “Sym Con” sample
F.J. Pino Calderon
1 ,∗
, J.M. Zoido Ramos
2, J.R. Gutierrez Casares
31
Servicio Extreme˜no de Salud, ESM Montijo-Puebla, Montijo, Spain
2
Servicio Extreme˜no de Salud, CEDEX “Los Pinos”, Badajoz, Spain
3
Servicio Extreme˜no de Salud, Hospital Perpetuo Socorro, Psichiatría,
Badajoz, Spain
∗
Corresponding author.
Introduction
The general data of this sample were presented in
“ADHD symptomatic contamination in a Dual Pathology (I): Gen-
eral Analysis of the Sym Con Sample”. We evaluated the presence
of symptomatic contamination by ADHD in a SUD group compared
with a group of non-consumers adults (parents of children treated
in a CAP unit).
Objective and aims
Describe more specifically the peculiarities of
the sample Sym Con according to the type of substance consump-
tion (Alcohol [
n
= 65], Cocaine [
n
= 48], Cannabis [
n
= 49] assessing
the presence of ADHD symptomatic contamination.
Methods
We use differents Visual Analogical Scales plus the
WURS, BDI, and Exploratory Lists of symptoms of ADHD.
Results
As can be seen in
Tables 1 and 2 ,the subgroup of Alco-
hol has a poorer “scalar” status with worse general state, more
sadness and anxiety, being the subgroup of cocaine themost “suspi-
cious”. The presence of ADHD-symptomatic contamination is more
noticeable in the Cannabis subgroup.
Conclusions
ADHD symptomatic contamination in our Sym Con
sample is frequent, being the cannabis subgroup the more
contaminated one. More studies that corroborate the results
obtained in this sample are required.
Table 1
Informe.
Table 2
Anova de un factor.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.1376EV392
Comorbidity between delusional
disorder and depression. Results from
the DelirAnda case register
A. Porras Segovia
1 ,∗
, C. Carrillo de Albornoz Calahorro
2,
M. Guerrero Jiménez
2, J. Cervilla Ballesteros
1 , 31
University hospital San Cecilio, mental health services, Granada,
Spain
2
Santa Ana hospital, mental health services, Motril, Spain
3
University of Granada, psychiatry department, Granada, Spain
∗
Corresponding author.
Introduction
Comorbidity between two ormoremental disorders
is highly frequent. Depression is one of the diseases that more often
accompanies other conditions.
Objectives
The objective of this study is to establish the preva-
lence of depression in patients with delusional disorder and
describe the treatment used in these cases.
Aims
The aim is to provide useful information regarding this fre-
quent, often disregarded, comorbidity.
Methods
Our results proceed from the Andalusian delusional dis-
order case register. We reviewed 1927 clinical histories of patients
diagnosed of delusional disorder. Upon having verified the diagno-
sis, following DSM-V criteria, we recollected several data, including